In Silico Insights Reveal Fibronectin 1 as a Theranostic Marker in Gastric Cancer.

ABSTRACT: Gastric cancer (GC) is a complex and highly variable disease, ranking among the top five cancers diagnosed globally, and a leading cause of cancer-related deaths. Emerging from stomach lining cells amid chronic inflammation, it often advances to preneoplastic stages. Late-stage diagnoses and treatment challenges highlight the critical need for early detection and innovative biomarkers, motivating this study's focus on identifying theranostic markers through gene ontology analysis. By exploring deregulated biological processes, this study aims to uncover insights into cancer progression and associated markers, potentially identifying novel theranostic candidates in GC. Using public data from The Human Protein Atlas, this study pinpointed 299 prognostic genes, delineating 171 with unfavorabl

SUBMITTER: Millapan T 

PROVIDER: S-EPMC11507984 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature